centronuclear
Showing 1 - 10 of 10
Natural History Study of Patients With Centronuclear Myopathies
Withdrawn
- Centronuclear Myopathy
- (no location specified)
Jul 7, 2022
Muscle Fatigability of Patients With Congenital Myopathies.
Not yet recruiting
- Central Core Disease
- +3 more
- Natural history and non therapeutical therapy
-
Nijmegen, Gelderland, Netherlands
- +1 more
Nov 27, 2023
Molecular and Genetic Studies of Congenital Myopathies
Recruiting
- Central Core Disease
- +7 more
-
Boston, MassachusettsGenetics Division, Boston Children's Hospital
Sep 7, 2021
Congenital Myopathy, Neuromuscular Diseases, Musculoskeletal Diseases Trial in Gothenburg (Salbutamol (as Salbutamol Sulfate) 2
Enrolling by invitation
- Congenital Myopathy
- +5 more
- Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet
- Salbutamol Only Product in Oral Dose Form
-
Gothenburg, Västra Götaland, SwedenSahlgrenska university hospital
Jan 10, 2022
Centronuclear Myopathy Trial in Worldwide (Standardized strength, respiratory and motor function assessments)
Unknown status
- Centronuclear Myopathy
- Standardized strength, respiratory and motor function assessments
-
Liège, Belgium
- +10 more
Nov 23, 2020
Natural History and Functional Status of Myotubular Myopathy
Completed
- Myotubular Myopathy
-
Boston, Massachusetts
- +12 more
Jun 6, 2018
Pompe Disease Trial in Gainesville (Pyridostigmine Bromide)
Terminated
- Pompe Disease
- Pyridostigmine Bromide
-
Gainesville, FloridaUniversity of Florida Clinical Research Center
May 9, 2018
Myotubular Myopathy Genetic Testing Study
Completed
- Myotubular Myopathy
- Genetic Testing
-
Torrance, CaliforniaCongenital Muscle Disease International Registry
Mar 5, 2018
Neuromuscular Disease Trial run by the NINR (N-acetylcysteine, Placebo)
Completed
- Neuromuscular Disease
- N-acetylcysteine
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 9, 2019